Contents

Search


recombinant asparaginase erwinia chrysanthemi-rywn (Rylaze)

Indications: - acute lymphocytic leukemia* * for patients allergic to asparaginase products derived from Escherichia coli Notes: - Jazz Pharmaceuticals

General

asparaginase (Elspar) recombinant protein; chimer

References

  1. Bankhead C FDA OKs Key Component of Acute Leukemia Regimen Recombinant asparaginase fills need for patients allergic to standard products. MedPage Today July 1, 2021 https://www.medpagetoday.com/oncology/leukemia/93380